These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25952969)

  • 1. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.
    Yee CS; Xie L; Hatsell S; Hum N; Murugesh D; Economides AN; Loots GG; Collette NM
    Bone; 2016 Jan; 82():122-34. PubMed ID: 25952969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endochondral fracture healing with external fixation in the Sost knockout mouse results in earlier fibrocartilage callus removal and increased bone volume fraction and strength.
    Morse A; Yu NY; Peacock L; Mikulec K; Kramer I; Kneissel M; McDonald MM; Little DG
    Bone; 2015 Feb; 71():155-63. PubMed ID: 25445453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice.
    Soung do Y; Gentile MA; Duong LT; Drissi H
    Bone; 2013 Jul; 55(1):248-55. PubMed ID: 23486186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
    Loiselle AE; Lloyd SA; Paul EM; Lewis GS; Donahue HJ
    PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair.
    Baht GS; Nadesan P; Silkstone D; Alman BA
    Bone; 2017 May; 98():31-36. PubMed ID: 28254468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent effects of sclerostin antibody on a mouse fracture healing model.
    Cui L; Cheng H; Song C; Li C; Simonet WS; Ke HZ; Li G
    J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):178-84. PubMed ID: 23728104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Sclerostin Depletion Stimulate Fracture Healing in a Mouse Model?
    Alzahrani MM; Rauch F; Hamdy RC
    Clin Orthop Relat Res; 2016 May; 474(5):1294-302. PubMed ID: 26608966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene.
    Li C; Ominsky MS; Tan HL; Barrero M; Niu QT; Asuncion FJ; Lee E; Liu M; Simonet WS; Paszty C; Ke HZ
    Bone; 2011 Dec; 49(6):1178-85. PubMed ID: 21890008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin Neutralizing Antibody Treatment Enhances Bone Formation but Does Not Rescue Mechanically Induced Delayed Healing.
    Kruck B; Zimmermann EA; Damerow S; Figge C; Julien C; Wulsten D; Thiele T; Martin M; Hamdy R; Reumann MK; Duda GN; Checa S; Willie BM
    J Bone Miner Res; 2018 Sep; 33(9):1686-1697. PubMed ID: 29694687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of beta-catenin signaling by Pb leads to incomplete fracture healing.
    Beier EE; Sheu TJ; Buckley T; Yukata K; O'Keefe R; Zuscik MJ; Puzas JE
    J Orthop Res; 2014 Nov; 32(11):1397-405. PubMed ID: 25044211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
    Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
    Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
    Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
    Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.
    Kayal RA; Tsatsas D; Bauer MA; Allen B; Al-Sebaei MO; Kakar S; Leone CW; Morgan EF; Gerstenfeld LC; Einhorn TA; Graves DT
    J Bone Miner Res; 2007 Apr; 22(4):560-8. PubMed ID: 17243865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells.
    Collette NM; Yee CS; Hum NR; Murugesh DK; Christiansen BA; Xie L; Economides AN; Manilay JO; Robling AG; Loots GG
    Bone; 2016 Jul; 88():20-30. PubMed ID: 27102547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper.
    Goldhahn J; Féron JM; Kanis J; Papapoulos S; Reginster JY; Rizzoli R; Dere W; Mitlak B; Tsouderos Y; Boonen S
    Calcif Tissue Int; 2012 May; 90(5):343-53. PubMed ID: 22451221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
    Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE
    J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing.
    Chen Y; Whetstone HC; Lin AC; Nadesan P; Wei Q; Poon R; Alman BA
    PLoS Med; 2007 Jul; 4(7):e249. PubMed ID: 17676991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfated hyaluronan improves bone regeneration of diabetic rats by binding sclerostin and enhancing osteoblast function.
    Picke AK; Salbach-Hirsch J; Hintze V; Rother S; Rauner M; Kascholke C; Möller S; Bernhardt R; Rammelt S; Pisabarro MT; Ruiz-Gómez G; Schnabelrauch M; Schulz-Siegmund M; Hacker MC; Scharnweber D; Hofbauer C; Hofbauer LC
    Biomaterials; 2016 Jul; 96():11-23. PubMed ID: 27131598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency of endogenous parathyroid hormone-related peptide impairs bone fracture healing.
    Wang YH; Qiu Y; Han XD; Xiong J; Chen YX; Shi HF; Karaplis A
    Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):715-23. PubMed ID: 23937065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.